Search Results Search Sort by RelevanceMost Recent Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226. Medicine and Society Mar 2022 Why Equitable Access to Vaginal Birth Requires Abolition of Race-Based Medicine Nicholas Rubashkin, MD, PhD More cesarean deliveries among Black and Hispanic women in the United States has long demonstrated racial inequity in obstetrical care. AMA J Ethics. 2022;24(3):E233-238. doi: 10.1001/amajethics.2022.233. Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296. Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514. Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519. Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Viewpoint Oct 2021 Whoever Does Image-Guided Palliative Care Needs to Be Properly Trained to Do So Jay A. Requarth, MD Some clinicians offering image-guided procedures have little training in palliative medicine, which is both a clinical and an ethical problem. AMA J Ethics. 2021;23(10):E826-831. doi: 10.1001/amajethics.2021.826. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022;24(3):E226-232. doi: 10.1001/amajethics.2022.226.
Medicine and Society Mar 2022 Why Equitable Access to Vaginal Birth Requires Abolition of Race-Based Medicine Nicholas Rubashkin, MD, PhD More cesarean deliveries among Black and Hispanic women in the United States has long demonstrated racial inequity in obstetrical care. AMA J Ethics. 2022;24(3):E233-238. doi: 10.1001/amajethics.2022.233.
Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022;24(4):E296-304. doi: 10.1001/amajethics.2022.296.
Case and Commentary Jul 2021 When Symptoms Aren’t Visible or Measurable, How Should Disability Be Assessed? Cerise L. Glenn, PhD Patients writing daily journal briefs about work-related activities and pain can help clinicians help them. AMA J Ethics. 2021;23(7):E514-518. doi: 10.1001/amajethics.2021.514.
Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519.
Medicine and Society Jul 2021 Questioning Biomedicine’s Privileging of Disease and Measurability Camille Kroll, MA Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences. AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
Viewpoint Oct 2021 Whoever Does Image-Guided Palliative Care Needs to Be Properly Trained to Do So Jay A. Requarth, MD Some clinicians offering image-guided procedures have little training in palliative medicine, which is both a clinical and an ethical problem. AMA J Ethics. 2021;23(10):E826-831. doi: 10.1001/amajethics.2021.826.